BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 8649821)

  • 1. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
    Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
    Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
    Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.
    Hodge DR; Robinson L; Watson D; Lautenberger J; Zhang XK; Venanzoni M; Seth A
    Oncogene; 1996 Jan; 12(1):11-8. PubMed ID: 8552380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-activation of heparanase promoter by ETS transcription factors.
    Lu WC; Liu YN; Kang BB; Chen JH
    Oncogene; 2003 Feb; 22(6):919-23. PubMed ID: 12584571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53.
    Iotsova V; Crépieux P; Montpellier C; Laudet V; Stehelin D
    Oncogene; 1996 Dec; 13(11):2331-7. PubMed ID: 8957074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A.
    Wen SC; Ku DH; De Luca A; Claudio PP; Giordano A; Calabretta B
    Exp Cell Res; 1995 Mar; 217(1):8-14. PubMed ID: 7867724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites.
    Galang CK; Der CJ; Hauser CA
    Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.
    Youn BS; Kim KK; Kwon BS
    J Immunol; 1996 Oct; 157(8):3499-509. PubMed ID: 8871649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.